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E-mail address: mtollenaar@fsw.leidenuniv.nl (M.SBackground: While acute cortisol administration has been found to impair retrieval of emotional mem-
ories in healthy subjects, the duration of this memory impairment is still unknown. Propranolol, on
the other hand, may impair the reconsolidation of emotional memories during reactivation, although
human studies examining such effects are scarce. The present investigation was therefore undertaken
to examine the immediate and prolonged effects of a single administered dose of cortisol or propranolol
on memory retrieval in a double-blind placebo controlled design.
Methods: Eighty-ﬁve healthy male participants were asked to retrieve previously learned emotional and
neutral information after ingestion of 35 mg cortisol, 80 mg propranolol or placebo. After a washout per-
iod of 1 week, recall was again tested.
Results: Memory retrieval of neutral and emotional information was impaired by a single dose of cortisol
compared to placebo. The memory impairment due to cortisol remained, even after a washout period of 1
week. No immediate or prolonged effects of propranolol on memory retrieval were found, despite signif-
icant reductions in sympathetic arousal.
Conclusions: These results lend support to the hypothesis that cortisol is able to attenuate (emotional)
memory recall in men over longer time spans and may therefore augment the treatment of disorders like
post-traumatic stress disorder and phobias, but do not clarify the mechanism(s) through which propran-
olol exerts its therapeutic effects.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Stress hormones like (nor)adrenaline (NA) and cortisol have
since long been found to inﬂuence memory processes (Cahill, Prins,
Weber, & McGaugh, 1994; Lupien & McEwen, 1997; Wolf, 2008).
Brain areas that are thought to mediate memory processes, like
the hippocampus, the prefrontal cortex and for emotional memory,
the amygdala, are highly occupied with both adrenergic and gluco-
corticoid receptors (de Kloet, Vreugdenhil, Oitzl, & Joels, 1998; Ra-
mos & Arnsten, 2007). Cortisol is released by the adrenal cortex
and can cross the blood-brain barrier (BBB) while NA is released
both peripherally by the adrenal medulla and within the brain as
a neurotransmitter (van Stegeren et al., 2007; Wolf, 2008). The
interaction between memory processes and stress hormones has
been an area of interest in the last two decades (Cahill, Gorski, &
Le, 2003; de Kloet, Oitzl, & Joels, 1999; Joels, Pu, Wiegert, Oitzl, &
Krugers, 2006; Lupien & Lepage, 2001; Wolf, 2008).ll rights reserved.
. Tollenaar).It has been found that the effects of human stress hormones on
memory are dependent on the memory stage that is studied (Roo-
zendaal, 2002). Encoding and consolidation phases of memory in
humans are found to be enhanced by increased cortisol and NA lev-
els (Andreano & Cahill, 2006; Buchanan & Lovallo, 2001; Cahill &
Alkire, 2003; O’Carroll, Drysdale, Cahill, Shajahan, & Ebmeier,
1999) and impaired by beta-adrenergic blockers like propranolol
that cross the BBB (Cahill et al., 1994; van Stegeren, Everaerd, Ca-
hill, McGaugh, & Gooren, 1998). Retrieval, on the other hand, is
found to be impaired by increased cortisol levels (de Quervain,
Roozendaal, Nitsch, McGaugh, & Hock, 2000; Het, Ramlow, & Wolf,
2005). Furthermore, this impairment seems to be dependent on
the activity of the adrenergic system (Kuhlmann & Wolf, 2006;
Roozendaal, Hahn, Nathan, de Quervain, & McGaugh, 2004; Toll-
enaar, Elzinga, Spinhoven, & Everaerd, 2008a). There are no reports
of increased levels of NA leading to impairment in memory retrie-
val in humans (see Chamberlain, Muller, Blackwell, Robbins, &
Sahakian, 2006, for an overview of studies on NA and memory).
A single human study, whereby NA levels were manipulated by
blockade with propranolol (40 mg) and memory retrieval was
measured, has been reported and did not ﬁnd an effect on memory
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studies investigating the effects of different doses of propranolol
on memory retrieval are needed to clarify this relation.
Recent animal studies have suggested that when memories are
retrieved, they are consolidated again after a labile period during
which the reactivated memories are prone to change. This process
is often referred to as reconsolidation (Debiec, Doyere, Nader, & Le-
Doux, 2006; Nader, Schafe, & Le Doux, 2000; Przybyslawski & Sara,
1997). Post-retrieval administration of propranolol has been found
to disrupt spatial memory and inhibitory avoidance learning in ro-
dents (Przybyslawski, Roullet, & Sara, 1999), as well as auditory
fear conditioning (Debiec & Ledoux, 2004), and both ﬁndings have
been explained in terms of impaired reconsolidation processes.
Tronel and Alberini (2007) have recently shown that reconsolida-
tion might also be dependent on the glucocorticoid system, as they
found that a glucocorticoid receptor antagonist can disrupt condi-
tioned fear in rats after reactivation of an inhibitory avoidance
memory. In line with that, Maroun and Akirav (2007) have found
an impairing effect of stress on reconsolidation in rats, which
was reversed by a glucocorticoid receptor antagonist. However,
cortisol may also impair memory after reactivation by enhancing
extinction rather than reducing reconsolidation (Abrari, Rashidy-
Pour, Semnanian, & Fathollahi, 2008; Cai, Blundell, Han, Greene,
& Powell, 2006). In the present study we will therefore merely refer
to reconsolidation as the post-retrieval stage during which memo-
ries might be prone to change.
While reconsolidation of fear related memories has most often
been studied in animals, human declarative memories may also
become labile during reactivation (Hupbach, Gomez, Hardt, & Na-
del, 2007; Walker, Brakeﬁeld, Hobson, & Stickgold, 2003). Human
studies on reconsolidation and the effects of cortisol and NA on this
process are scarce. In a previously reported study, we examined
the effects of elevated stress hormones on post-retrieval processes
in humans (Tollenaar, Elzinga, Spinhoven, & Everaerd, 2008b). In
line with animal studies (Maroun & Akirav, 2007), a post-retrieval
decline in memory performance was observed when memories
were reactivated during stress (5 weeks after encoding). However,
whether cortisol or other stress hormones were active in this pro-
cess remains unclear. The effect of blocking adrenergic activity
during memory reactivation has recently been studied in humans
by Brunet et al. (2008) and Miller, Altemus, De˛biec, LeDoux, and
Phelps (2004). Miller and colleagues reported that fear condition-
ing was reduced when a conditioned cue was reactivated and fol-
lowed by NA beta-blockade. In addition, Brunet and colleagues
found that post-retrieval propranolol reduced psycho-physiologi-
cal responding to mental imagery of a past traumatic event in
post-traumatic stress disorder (PTSD). However, the effects of pro-
pranolol on human declarative memory reconsolidation still re-
main to be elucidated.
Knowledge on the impact of (stress) hormones on human mem-
ory retrieval and reconsolidation is of therapeutic interest, since
reducing the recall and/or experience of (intrusive) emotional
memories might be of use in augmenting treatments for stress-re-
lated disorders like PTSD. Several studies have examined the utility
of cortisol and a beta-adrenergic blocker (propranolol) in the treat-
ment of PTSD. These studies have shown promising results, with
reductions in re-experiencing and chronic stress symptoms after
cortisol administration (Aerni et al., 2004;Weis et al., 2006) and re-
duced physiological reactivity after propranolol treatment (Brunet
et al., 2008; Pitman et al., 2002; Vaiva et al., 2003). Phobic fears and
mood responses to stress also seem to be reduced by cortisol
administration (Het & Wolf, 2007; Soravia et al., 2006).
To gain more insight into the effects of cortisol and propranolol
on memory retrieval and reconsolidation, the present study inves-
tigated the effects of 35 mg hydrocortisone and 80 mg propranolol
on memory retrieval and post-retrieval processes in healthy youngmen. By testing memory retrieval both during elevated cortisol or
lowered NA levels and 1 week later (after clearance of the drug),
the immediate treatment effects of cortisol and propranolol on
memory retrieval were investigated, as well as whether these ef-
fects were prolonged up to 1 week later. We expected impairing ef-
fects of cortisol on memory retrieval, both immediate and
prolonged. We had no expectations on the immediate effects of
propranolol on memory retrieval, but did expect an impairing ef-
fect on reconsolidation, reﬂected in retrieval impairments 1 week
after treatment.
2. Methods
2.1. Participants
Eighty-ﬁve Dutch male students were recruited through adver-
tisements at colleges and the University of Leiden. Only men were
selected because of possible confounding effects of menstrual cycle
and contraceptive pills on the relation of cortisol and propranolol
treatment with memory (Cahill & van Stegeren, 2003; Kuhlmann
& Wolf, 2005). Participants were screened before inclusion. Inclu-
sion criteria were: no reported history of disease or psychiatric
problems, no current use of prescribed medication including corti-
costeroid containing ointments, no chronic disease requiring med-
ical attention including diabetes, allergies and asthma, no use of
psychotropic drugs, alcohol intake under 20 glasses per week,
smoking less than 10 cigarettes per day, age between 18 and 35
years, an estimated Body Mass Index (BMI) between 19 and 26
and blood pressure levels over 100/70 mmHg. Before participation,
written informed consent was obtained and after participation par-
ticipants were rewarded with either course credits or a monetary
compensation (40 Euros). The study protocol was approved by
the Medical Ethics Committee of the Leiden University Medical
Centre.
To minimize inﬂuences on baseline cortisol levels, participants
were instructed to refrain from drinking any sweet or caffeinated
drinks and eating heavy meals on the morning of the second (treat-
ment) session. Furthermore, they were instructed not to eat or
drink anything but water, and not to smoke an hour before the sec-
ond session would start.
Of the 85 recruited participants, 2 men were excluded after the
ﬁrst session due to low blood pressure. Two participants were ill
during one of the sessions and one person dropped out after the
ﬁrst session. We excluded one more participant due to problems
with his Dutch written language. Hence, 79 participants completed
the study. Participants were randomly assigned to one of three
experimental groups in a double blind between subjects design
(placebo: N = 27, cortisol: N = 26, propranolol: N = 26). Dependent
on group, 35 mg hydrocortisone, 80 mg propranolol or a placebo
was administered orally, in identical capsules.
Table 1 shows the demographic variables of the participants per
group. No differences between groups were found for BMI, anxiety
(STAI-trait) and general psychopathology (Symptoms Checklist,
SCL-90). Age was signiﬁcantly lower in the placebo group com-
pared to the cortisol group (t(32) = 2.42, p < .05) and depression
scores on the Beck Depression Inventory (BDI-II) were marginally
higher in the control group compared to both the cortisol
(t(46) = 1.83, p = .07) and propranolol group (t(50) = 1.95, p = .06).
2.2. Memory and attention tasks
To measure memory retrieval a word task adapted from Her-
mans and de Houwer (1994) and Smeets, Jelicic, and Merckelbach
(2006) was employed. Thirty emotional and 30 neutral words were
selected that were matched on familiarity and word length. Fifteen
words from each category were used for the retrieval task and the
Table 1
Demographic variables (mean ± SD)
Group Placebo (N = 27) Cortisol (N = 26) Propranolol (N = 26)
Age 19.51 (1.37)a 21.35 (3.61)a 20.62 (2.16)
BMI 22.07 (2.35) 22.40 (1.98) 21.69 (2.07)
Depression (BDI-II) 6.59 (4.39)b 4.69 (3.04)b 4.44 (3.48)b
Anxiety (STAI trait) 33.74 (9.08) 33.73 (9.08) 31.38 (6.97)
Psychopathology
(SCL-90)
28.19 (24.83) 28.73 (23.23) 28.00 (20.25)
Note. BMI = Body Mass Index; BDI-II = Beck Depression Inventory II; SCL-
90 = Symptom Checklist-90.
a Signiﬁcant difference in age between the placebo and cortisol group (p < .05).
b Marginally signiﬁcant difference in depression scores between the placebo
group and the cortisol and propranolol group (p < .10)
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Fig. 1. (a) Schematic overview of the 3 sessions. (b) Schematic overview of the
second session. Treatment consisted of either cortisol (35 mg), propranolol (80 mg)
or a placebo. The memory tasks were a free recall, cued recall and working memory
task.
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the ﬁrst session, words were randomly presented on a 17 in. com-
puter screen for 4 s (word height: 13 mm, distance to screen:
60 cm). After presentation of each word, participants rated the
word on two standardized, 5-point Likert scales on arousal (emo-
tionality) and valence from the Self-Assessment Manikin (SAM:
Bradley & Lang, 1994). A higher score on the arousal scale indicates
higher emotionality and on the valence scale more negative emo-
tions. After presentation of the words, a surprise memory task
was given in which participants had to write down as many words
as they could remember within 4 min (free recall). Then the same
words were presented a second time, but with the deliberate
instruction to remember as many words as possible. Words were
presented for 5 s with 2 s intervals in between. A free recall test
was again administered afterwards. These two trials served as
the encoding/learning trials. During the second session, free recall
of the words was again tested (in written form) with a maximum
time of 4 min, followed by a cued recall task in which the ﬁrst let-
ters of each word were given and participants were asked to write
down as many words as they could remember in 5 min. The third
session consisted of a last free recall task, followed by a recognition
task in which the old words were mixed with (15 neutral and 15
negative) new words and displayed on a computer screen. Partici-
pants were required to make a forced classiﬁcation of words as old
or new.
To obtain an estimate of verbal working memory, the digit span
forward and backward from the WAIS were administered (WAIS,
1970; WAIS-III, 1997). Two versions of each task were randomly
varied between the ﬁrst and second session. In the forward condi-
tion, participants had to recall strings of numbers ranging from 4 to
8 in length. In the backward condition, participants had recall
strings of numbers in a backward fashion.
To get an estimate of attention, the Sustained Attention to Re-
sponse Task (SART) was administered, measuring vigilance (Manly,
Robertson, Galloway, & Hawkins, 1999). In this task, digits between
1 and 9 were presented for 250 ms in one of ﬁve randomly as-
signed font sizes with an inter-stimulus interval of 900 ms. Partic-
ipants were asked to press a key (as fast as possible) in response to
the digits except for the number 3. Misses and errors of commis-
sion were added to calculate an overall error score. Additional
tasks were administered during the study that will be described
in future reports.
2.3. Physiological and subjective measures
Saliva samples were obtained using Salivettes (Sarstedt, Ger-
many) to measure unbound cortisol and alpha-amylase levels. Al-
pha-amylase has been shown to be an estimate of adrenergic
activity (Nater et al., 2006; Rohleder, Nater, Wolf, Ehlert, & Kirsch-
baum, 2004) and is sensitive to beta-blockage by propranolol (van
Stegeren, Rohleder, Everaerd, & Wolf, 2005). Saliva samples were
stored at -20 C prior to analyses. The saliva samples wereanalyzed by the Kirschbaum lab, Technical University of Dresden
(see Rohleder, Wolf, Maldonado, & Kirschbaum, 2006).
Heart rate and blood pressure were measured to asses adrener-
gic functioning using an automatic upper arm blood pressure mon-
itor (OMRON, M6). In addition to each physiological recording,
participants were given a questionnaire with 7 questions on sub-
jective experiences like anxiety, mood and motivation. Answers
were given on Visual Analogue Scales (VAS) of 100 mm in length,
leading to a score from 0 to 100 on each scale.
2.4. Questionnaires
The BDI-II (Beck, Steer, & Brown, 1996; van der Does, 2002) was
administered to assess depressive feelings in the past 2 weeks, a
Dutch version of the STAI-trait (Spielberger, 1983) to measure
the level of generalized anxiety and the SCL-90 (Arrindell & Ettema,
1986) to assess psychological symptoms and psychopathology dur-
ing the last week.
2.5. Procedure
Participants came to a lab at the Faculty of Social and Behavioral
Sciences in Leiden for 3 sessions. The interval between each session
was 1 week (see Fig. 1a for an overview of the 3 test sessions). On
the ﬁrst session screening measurements of blood pressure and
heart rate were taken after 3 rest periods of 4 min. During this ﬁrst
session, words were encoded for the retrieval task and baseline
working memory performance was measured. At the start of the
second session, after a 4 min rest period (given before each physi-
ological measurement), baseline measurements of heart rate and
blood pressure were assessed and baseline saliva samples ob-
tained. Participant then ingested a capsule containing placebo,
35 mg hydrocortisone or 80 mg propranolol. During the next
75 min, participants completed several computer based question-
naires and were instructed to remain in the lab and read (reading
material was provided). At t = 75 min after ingestion, participants
heart rate and blood pressure were again assessed and saliva mea-
surements obtained. Memory was then tested, including working
memory. Physiology was measured again at 110 min after treat-
ment after which an attention task was given. At 135 min after
treatment, the last physiological measurements were taken as well
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task (see Fig. 1b for an overview of session 2). In the third session,
memory was tested again followed by an exit interview (including
expectancies of the last memory task and an awareness check for
treatment) as well as a debrieﬁng concerning the goals of the
study.
2.6. Data analysis
The effects of the treatment (placebo vs. cortisol vs. proprano-
lol) on physiological and subjective measures were analyzed using
repeated measure (RM-) ANOVAs with time as within-subject and
group as between-subject variable, followed by Student Newman
Keuls (SNK) post hoc tests. A v2 test was used to analyze side effects
and treatments awareness in the three groups. Memory retrieval
over the three sessions was analyzed using a RM-ANOVA with ses-
sion and emotion as within-subject and group as between-subject
variable. The percentages correct recall on session 2 and 3 were
also analyzed using RM-ANOVAs with emotion as within subject
and group as between subject factor. Additional analyses were con-
ducted using univariate ANOVAs or simple t-tests. Greenhouse-
Geisser corrected p values were used when indicated by violated
Sphericity. Analyses were performed with SPSS 14.0 (SPSS,
Chicago, IL). The criterion for statistical signiﬁcance was p < 0.05.
3. Results
3.1. Effect of treatments on physiology
3.1.1. Cortisol measures
Table 2 shows the salivary cortisol levels in the three groups in
nmol/L. For the RM-ANOVA, log values of cortisol were calculated
to account for non-normality. One participant in the propranolol
group was excluded from the analyses due to a missing sample.
A signiﬁcant group by time interaction was found (F(3,107) =
30.16, p < .001). As expected, Student Newman Keuls (SNK) post
hoc analyses revealed that cortisol levels were signiﬁcantly in-
creased in the cortisol group compared to both the placebo and
propranolol group at t = 75, 110 and 135 min (all p’s < .01), while
not differing from the other 2 groups at baseline, t = 0 min
(p > .50). In addition, a group by time interaction was also found
between the placebo and propranolol group (F(2,87) = 10.26,
p < .001). The propranolol group showed increased cortisol levels
compared to placebo at t = 110 and t = 135 (both p’s < .01).
3.1.2. Adrenergic measures
Fig. 2a–d shows the changes in alpha-amylase (AA), heart rate
(HR), systolic (SBP) and diastolic blood pressure (DBP) in all groups
before (t = 0) and at three time points after treatment (t = 75, 110
and 135 min) on session 2.
For the RM-ANOVA, log values of AA were calculated to account
for non-normality. Four participants were excluded from the anal-
yses due to missing AA samples (n = 2 from the propranolol, n = 1Table 2
Free salivary cortisol in nmol/L (±SEM) in each treatment group
Group Time
t = 0 t = 75 t = 110 t = 135
Placebo 9.01 (0.69) 5.02 (17.20) 4.57 (8.85) 4.95 (5.45)
Cortisol 7.47 (0.71) 206.61 (17.53)a 134.79 (9.01)a 99.37 (5.55)a
Propranolol 7.98 (0.72) 5.84 (17.88) 8.26 (9.19)b 9.81 (5.66)b
a Signiﬁcant increase in cortisol levels in the cortisol group vs. the placebo and
propranolol group (p < .001).
b Signiﬁcant increase in cortisol levels in the propranolol group vs. the placebo
group (p < .001).from the cortisol and n = 1 from the placebo group). A signiﬁcant
interaction between group and time was found for AA levels
(F(4,160) = 5.33, p < .001). SNK post hoc tests revealed that AA lev-
els were marginally lower in the propranolol group compared to
both the placebo and cortisol group at t = 75 (p = .09) and
110 min (p = .06) and signiﬁcantly lower at 135 min (p < .02), while
not differing from the other 2 groups at baseline, t = 0 min (p > .20).
A signiﬁcant group by time interaction was also found for HR
(F(4,134) = 6.03, p < .001). SNK post hoc analyses revealed that HR
levels were signiﬁcantly decreased in the propranolol group com-
pared to both the placebo and cortisol group at t = 75, 110 and
135 min (all p’s < .01), while not differing from the other 2 groups
at baseline, t = 0 min (p > .80).
Similar results were found for SBP. The group by time interac-
tion was signiﬁcant (F(4,171) = 9.41, p < .001) and SNK post hoc
analyses revealed that SBP levels were signiﬁcantly decreased in
the propranolol group compared to both the placebo and cortisol
group at t = 75 (p < .03), 110 (p < .02) and 135 min (p < .01), while
not differing from the other 2 groups at baseline, t = 0 min
(p > .40). Even though an interaction was found for group by time
for DBP as well (F(5,180) = 2.91, p < .05), SNK post hoc tests re-
vealed no signiﬁcantly lower DBP at any of the time point in the
propranolol group vs. the other groups (all p’s > .10).
3.1.3. Subjective measures
No effects of treatment over time were found on subjective feel-
ings of tension, insecurity, irritation, motivation, mood and tired-
ness (all p’s > .10). We did ﬁnd an interaction effect of group with
time on anxiety (F(5,186) = 2.30, p < .05). The propranolol group
showed a trend towards lower anxiety at the end of the 2nd ses-
sion compared to the placebo group (t(46) = 1.74, p = .09).
3.1.4. Side-effects and awareness check
After the treatment session participants were asked to report
any side-effects or strange feelings. Feelings that were reported in-
cluded: tiredness, tense feeling, cold hands, headache, light nausea
and concentration problems. However, each of these reported feel-
ings were evenly distributed across the 3 treatment groups
(Pearson’s v2 (6) = 5.35, p = .50). Furthermore, in the exit interview,
participants were asked to speculate which treatment they re-
ceived to check for awareness of treatment. Answers were catego-
rized as placebo, cortisol, propranolol, no idea or simply a
medicine. Participants did not guess which treatment they re-
ceived (Pearson v2 (8) = 6.96, p = .54).
3.2. Memory performance
3.2.1. Arousal and valence ratings
On average, negative words were rated as signiﬁcantly more
emotional (mean = 2.76, SD = 0.74) than neutral words (mean =
1.70, SD = 0.55, t(78) = 16.24, p < .001). Negative words were also
rated as signiﬁcantly more negatively valenced (mean = 3.79,
SD = 0.53) than neutral words (mean = 2.72, SD = 0.38, t(78) =
22.25, p < .001). No differences in ratings were found between
the three groups (all p’s > .10).
3.2.2. Memory performance
Table 3 shows performance on the memory tasks on sessions 1,
2 and 3. For session 1 recall performance on the last learning trial is
shown. For session 2 data on the free recall and the cued recall task
are shown and for session 3 performance on the free recall and the
recognition task are shown.
In the RM-ANOVA used to test for effects of treatment on mem-
ory retrieval the last recall trial from session 1 and the free recall
trials from sessions 2 and 3 were analyzed. The RM-ANOVA with
session (1 vs. 2 vs. 3) and emotion (neutral vs. emotional) as with-
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Fig. 2. Physiological measures of adrenergic activation on session 2, before treatment (t = 0) and after treatment (t = 75, 110 and 135 min) (a) alpha-amylase, (b) heart rate, (c)
systolic blood pressure, (d) diastolic blood pressure. Mean levels ± SEM are displayed. *Signiﬁcant difference in the propranolol vs. the placebo and cortisol group (p < .01).
#Signiﬁcant difference in the propranolol vs. the placebo and cortisol group (p < .05).
Table 3
Memory performance (mean ± SD) on session 1, 2 and 3 in number of words correctly recalled
Group Word valence Session 1 Session 2 Session 3
Recall Recall Cued recall Recall Recognitiona
Placebo Neutral 8.63 (2.17) 4.70 (1.56) 6.11 (2.33) 5.22 (2.08) 10.52 (2.23)
Emotional 10.11 (2.31) 6.07 (2.73) 7.15 (2.43) 6.37 (2.39) 10.67 (2.63)
Cortisol Neutral 9.27 (1.85) 4.27 (2.18) 5.69 (2.29) 4.77 (1.80) 10.42 (2.89)
Emotional 10.42 (2.14) 5.46 (2.10) 6.58 (2.27) 5.42 (1.88) 9.31 (2.94)
Propranolol Neutral 9.35 (2.12) 5.54 (2.20) 6.42 (2.69) 5.85 (2.41) 11.73 (2.16)
Emotional 11.04 (1.64) 6.81 (2.12) 7.88 (1.75) 6.85 (1.99) 10.54 (3.09)
a Recognition scores were calculated by subtracting the falsely recognized items from the number of correctly recognized items.
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calculated for retrieval performance. A signiﬁcant main effect of
session was found (F(2,122) = 537.49, p < .001), showing a de-
crease in performance from session 1 to 2 (F(1,76) = 648.80,
p < .001) and a slight increase in performance from session 2 to 3
(F(1,76) = 6.59, p < .02) for all groups. This increase in recall perfor-
mance from the second to third week may be due to the cued recall
task that was performed after the free recall task of the second ses-
sion. Furthermore, a main effect of emotion was found
(F(1,76) = 26.83, p < .001) reﬂecting a higher recall of emotional
vs. neutral words.
No main effect of group was found. In line with our expecta-
tions, a signiﬁcant group by session interaction was found
(F(3,122) = 3.62, p = .013). With planned comparison analyses forthe cortisol and propranolol group separately, this interaction ap-
peared to be signiﬁcant between the placebo and cortisol group
(F(2,77) = 6.00, p < .01), but not between the placebo and propran-
olol group (F(2,89) = 0.35, p = .68). To clarify in which phase the
interaction effects for cortisol were apparent, separate RM-
ANOVAs were conducted on session 1 vs. session 2 and session 1
vs. session 3. In the ﬁrst RM-ANOVA with session 1 and session
2, and emotion as within-subject factors, and cortisol vs. placebo
as between-subjects factor, it was shown that memory perfor-
mance in the cortisol group decreased signiﬁcantly more from ses-
sion 1 to session 2 than in the placebo group (time  group
interaction: F(1,51) = 5.35, p = .025), while performance on session
1 did not differ between these groups (F(1,51) = 1.08, p = .30). This
interaction was also found in the RM-ANOVA with session 1 and 3
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Fig. 3. Percentage correct recall (mean ± SEM) on session 2 and 3 with respect to the last learning trial on session 1. The cortisol group showed a lower memory performance
on both session 2 and 3 compared to the placebo and propranolol groups (p’s < .05).
28 M.S. Tollenaar et al. / Neurobiology of Learning and Memory 91 (2009) 23–31as within-subjects variable (time  group interaction: F(1,51) =
8.81, p < .01), indicating a higher decrease in memory retrieval
from session 1 to 3 in the cortisol group compared to the placebo
group.
We also calculated the percentages correct recall on sessions 2
and 3 with respect to the last learning trial on session 1 (see Fig. 3).
RM-ANOVAs for the percentages correct recall on both session 2
and session 3 with emotion as within-subject factor, and cortisol
vs. placebo as between subjects factor, showed that the cortisol
group remembered signiﬁcantly less from the last learning trial
than the control group in both session 2 (F(1,51) = 4.17, p = .046)
and session 3 (F(1,51) = 6.60, p = .013). No interaction effects with
emotion were found (all p’s > .40), indicating that the immediate
and prolonged effects of cortisol on memory retrieval were similar
for both neutral and emotional memory retrieval. The propranolol
group did not remember less from the last learning trial than the
control group in either session 2 (F(1,51) = 0.37, p = .92) or session
3 (F(1,51) = .512, p = .48).
To examine the change in retrieval performance from session 2
to session 3, an additional RM-ANOVA with session 2 and session 3,
and emotion as within-subject factors, and group (cortisol vs. pro-
pranolol vs. placebo) as between-subjects factor was performed.
No interaction between group and time was found
(F(2,76) = 0.45, p = .64), indicating that memory after treatment
changed in a similar way in each group. In addition, when the per-
centage correct recall on session 3 was calculated with respect to
session 2 and compared between groups in an ANOVA, no effect
of group was found either (F(2,76) = 0.41, p = .67).
When conducting separate ANOVAs on the absolute scores on
each of the three sessions, no differences in recall performance
were found for any of the sessions between the placebo and the
treatment groups (all p’s > .10). Also, no effect of group was found
on cued recall or recognition scores (all p’s > .10).
In both sessions 2 and 3 participants were asked whether they
expected a memory test. In session 2, more participants expected a
memory task in the propranolol group (F(2,76) = 3.09, p = .05). Fur-thermore, as mentioned in the methods section, age and depres-
sion scores differed in the control group compared to the other 2
groups. Therefore, these 3 variables were subsequently entered
in the above analyses as covariates. Controlling for these possible
confounding variables did not affect the main interaction between
group (placebo, cortisol and propranolol) and session (sessions 1, 2,
and 3) (F(4,144) = 3.57, p = .014).
3.2.3. Working memory and attention
A RM-ANOVA with session (1 vs. 2) and order (forward vs. back-
ward) as within-subject variable and group as between-subject
variable was performed for the working memory scores on the di-
git span. Performance increased from session 1 to 2
(F(1,76) = 37.17, p < .001) and performance on digits forward was
higher than digits backward (F(1,76) = 19.46, p < .001). No effects
of group were found however (all p’s > .15). Moreover, an ANOVA
also failed to reveal signiﬁcant effects of group on errors in the sus-
tained attention task (F(2,76) = 1.51, p = .23).
4. Discussion
In this study we found evidence that the retrieval impairments
that have been observed as a result of cortisol administration are
still observable after a wash out period of 1 week. These immediate
and prolonged impairments in memory retrieval were found for
the retrieval of both neutral and emotional words. These results
are in line with earlier studies showing impairing effects of acute
cortisol administration on memory retrieval (de Quervain et al.,
2000; Het et al., 2005). They also relate to an earlier study by our
group (Tollenaar et al., 2008b) in which we found that stress im-
pairs long-term memory retrieval when memories are reactivated
during stress. While in the previous study stress was found to fur-
ther diminish long-term memory retrieval when memory was
reactivated during stress, in the present study we did not ﬁnd a
further decrease in memory performance after cortisol treatment.
The persistence of the retrieval impairment in the cortisol group
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lower re-encoding of the retrieved material or to the effects of cor-
tisol on post-retrieval (reconsolidation) processes. From these data
it cannot be concluded which of these two processes were involved
in the memory impairments 1 week after treatment. The differ-
ences found between the long-term effects of exogenous cortisol
administration and stress-induced endogenous cortisol increases
may be related to the additional physiological and psychological
responses that arise during stress. Furthermore, to examine
whether reconsolidation speciﬁcally is affected by cortisol, future
investigations should increase cortisol levels after memory reacti-
vation to separate the effects on retrieval and reconsolidation, and
compare the effects of cortisol not only to a placebo group, but also
to a group in which cortisol is administered without reactivation,
to rule out non-speciﬁc effects of cortisol on long-term memory.
In contrast to the impairing effects of cortisol, we found no
immediate effect of propranolol on memory retrieval. So far, only
one other study reported on the effects of propranolol on memory
retrieval (de Quervain et al., 2007). In this study, propranolol did
not reduce retrieval either. Furthermore, we found no indications
for effects of propranolol on post-retrieval processes. That is, per-
formance 1 week after treatment was still comparable to placebo.
This is in contrast with our expectations based upon studies in
which propranolol was found to affect post-retrieval processes
like reconsolidation (Debiec & Ledoux, 2004; Miller et al., 2004;
Przybyslawski et al., 1999). However, these studies used mostly
fear conditioning paradigms, which are not directly comparable
to our declarative memory task. While fear conditioning is con-
cerned with implicit learning, generally involves higher levels of
fear, and is found to be mediated by the amygdala (Debiec & Le-
Doux, 2006), memory retrieval is thought to be primarily medi-
ated by the hippocampus and prefrontal regions (Squire, Stark,
& Clark, 2004; Takashima et al., 2006), although the amygdala
has also been implicated in emotional memory retrieval (Dolcos,
LaBar, & Cabeza, 2005). A reason that might therefore explain
our non-results is that propranolol may be more involved in
(amygdala related) physiological and anxiety reducing mecha-
nisms, as in fear conditioning. Although we did ﬁnd a slight de-
crease in anxiety in the propranolol group at the end of the
treatment session, this effect did not remain 1 week after treat-
ment. Propranolol may potentially only affect declarative memory
reconsolidation when related emotions and physiological re-
sponses are very strong, as in PTSD (Orr, Metzger, & Pitman,
2002). That is, propranolol has been found to affect declarative
memory consolidation in humans (Cahill et al., 1994; van Stege-
ren et al., 1998), but in those studies picture tasks were used that
might have elicited more emotional arousal than our word task.
Another reason that could explain the non-results, is that the
administered dose of propranolol was too low. This is not a likely
explanation however, since the expected physiological effects of
propranolol administration were clearly observed. There was a
very signiﬁcant decrease in adrenergic activity measured with
heart rate and blood pressure (although only on systolic blood
pressure, as previously reported by Maheu, Joober, and Lupien
(2005) and van Stegeren et al. (2005)), but also with alpha-amy-
lase. Alpha-amylase measured from saliva seems to be a valid and
non invasive measure of adrenergic activity and is sensitive to
beta-adrenergic blockade (Nater et al., 2006; van Stegeren et al.,
2005). Besides the fact that propranolol induced the expected
physiological effects, we have administered a dose of propranolol
(80 mg) that was twice as high as in the study by de Quervain
et al. (2007). Taken together, even though we did not ﬁnd evi-
dence for effects of propranolol on reconsolidation, this study
does not rule out that propranolol might potentially play a role
in reconsolidation in humans. Reconsolidation in humans is still
a relatively unstudied area and future studies using differentmemory paradigms will have to elucidate whether propranolol
can affect post-retrieval memory processes.
Interestingly, propranolol also led to a moderate, but signiﬁcant,
increase in cortisol levels, which was previously reported by Ma-
heu, Joober, Beaulieu, and Lupien (2004) as well. Apparently, this
increase did not impair memory recall. The increase might not
have been sufﬁciently large to cause any effects (less than
2 nmol/L cortisol), but the fact that noradrenergic activation was
blocked by propranolol might have prevented cortisol increases
from any impairing effects on memory as well (see also de Quer-
vain et al., 2007).
Overall, the present ﬁndings suggest that reactivation of mem-
ories when cortisol levels are high may lead to long-term memory
attenuation. This is highly relevant for the treatment of post-trau-
matic stress disorder (PTSD), in which a lasting diminished recall of
trauma-related memories might be beneﬁcial (de Quervain, 2007).
Moreover, these ﬁndings are in accordance with clinical observa-
tions of prolonged beneﬁcial effects of glucocorticoids in PTSD
and phobias (de Quervain & Margraf, 2008). However, our ﬁndings
suggest that cortisol may impact both emotional and neutral mem-
ory retrieval. The role of emotionality and valence in the effect of
cortisol on memory retrieval in humans is still unclear. That is, sev-
eral other studies have found effects of cortisol on retrieval of neu-
tral memories as well (Buss, Wolf, Witt, & Hellhammer, 2004; de
Quervain et al., 2000), while other studies found effects of cortisol
primarily on emotional memory retrieval (Domes, Heinrichs,
Rimmele, Reichwald, & Hautzinger, 2004; Kuhlmann, Kirschbaum,
& Wolf, 2005a). The effects of endogenous increases of cortisol on
memory retrieval seem to be dependent on the emotionality of the
material or on an arousing context (Kuhlmann, Piel, & Wolf, 2005b;
Tollenaar et al., 2008a), while high exogenous doses of cortisol
might affect memory retrieval as long as the subject has a normal
level of sympathetic arousal (de Quervain et al., 2007; Kuhlmann &
Wolf, 2006). With regard to the clinical setting, the impairing ef-
fects of cortisol on the retrieval of neutral information may be a po-
tential negative side effect, and merit special attention in future
clinical trials.
There are some limitations to our current investigation that
merit consideration. The effects we found of cortisol on memory
retrieval were all within-subject effects. They were expressed in
an interaction between group and session and present in the per-
centage correct recall with respect to the individual last learning
trial. No effects were found on absolute memory scores when the
sessions were analyzed separately. Other studies have reported
within-subject effects of cortisol on memory retrieval as well (Buss
et al., 2004; Kuhlmann et al., 2005a; Kuhlmann et al., 2005b), sug-
gesting that these effects, while subtle, are consistent. Second, the
present study only included men, while disorders related to stress
and memory problems like PTSD and depression are highly preva-
lent in women. Future studies should examine whether similar re-
sults are found in females, while taking into account hormonal
ﬂuctuations due to menstrual cycle and birth control agents. An-
other point is that our control group differed from the drug groups
on depression and age scores despite randomization. In the control
group, two participants were over 30 years leading to a higher
mean. However, including both age and depression scores as
covariates in the analyses did not change our results. Furthermore,
the fact that the impairments in memory were prolonged up to 1
week does not necessarily mean that the memory traces are im-
paired indeﬁnitely. A longer follow-up is needed to indicate
whether these effects are persistent or temporary. Of interest is
also whether memory losses can be restored with cues or in a dif-
ferent context (Bouton, 2002). Moreover, future studies should
investigate the effects of multiple reactivations under treatment,
as animal research has indicated this might strengthen the effects
(Cai et al., 2006).
30 M.S. Tollenaar et al. / Neurobiology of Learning and Memory 91 (2009) 23–31In summary, these results lend support to the hypothesis that
cortisol might aid in the treatment of disorders like PTSD and pho-
bias by diminishing (emotional) memory recall over extended time
spans, but does not clarify the mechanisms through which pro-
pranolol exerts its therapeutic effects.
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